NT-proBNP bests BNP for heart failure testing

Heart failure affects many lives, and timely detection is key to better outcomes.

Our AmstelHeart group just published a study that sheds light on improving heart failure (HF) detection in primary care.
We compared the diagnostic accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) and found higher accuracy for the latter in a large Amsterdam-based primary care population.
But that's not all. We explored the potential of personalized thresholds based on age, sex, and other readily available parameters.
The outcome? A modest yet valuable improvement in diagnostic accuracy for both BNP and NT-proBNP compared to universal thresholds.
This research not only advances our understanding of HF diagnosis but also paves the way for more personalized healthcare.
Let's continue striving for better healthcare outcomes together!